Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer [Phase 2]
Phase 2 trial evaluating a combination of bevacizumab, lenalidomide, docetaxel, and prednisone (ART-P) for metastatic castration-resistant p…
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer [Phase 2]
Phase 2 trial investigating hormone therapy plus chemotherapy as initial treatment for local failures or advanced prostate cancer; the study…
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating hormone therapy with or without definitive radiotherapy in metastatic prostate cancer.
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating valproic acid in progressive, non-metastatic prostate cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: Preoperative Brimonidine on IOP of Patients Undergoing RALP [Phase 4]
Phase 4 clinical trial evaluating preoperative brimonidine on intraocular pressure in patients undergoing robotic-assisted laparoscopic pros…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-09-25Clinical Trial Update: A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer [Phase 2]
Phase 2 study evaluating sipuleucel-T with enzalutamide in metastatic castration-resistant prostate cancer has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2018-09-24Clinical Trial Update: Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer [Phase 2]
Phase 2 trial assessing abiraterone with radiotherapy and short-term androgen deprivation in unfavorable localized prostate cancer completed…
-
CLINICAL_TRIALS trial_result · 2018-09-21Clinical Trial Update: Evaluation of Addition of Dexamethasone to Transversus Abdominis Plane (TAP) Peripheral Nerve Block [NA]
Completed trial evaluating addition of dexamethasone to TAP nerve block in prostate cancer patients; results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis [Phase 3]
Phase 3 clinical trial update evaluating radium-223 dichloride in Asian patients with prostate cancer and bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Tivantinib in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update for tivantinib in metastatic prostate cancer has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating internal radiation therapy with or without external-beam radiation therapy in localized prostate ca…
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer [Phase 3]
Phase 3 trial update evaluating hormone therapy with or without mitoxantrone and prednisone in patients after radical prostatectomy for pros…
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial KHAD-L regimen (ketoconazole, hydrocortisone, dutasteride, lapatinib) in prostate cancer has been terminated with results po…
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating GM-CSF and thalidomide in patients undergoing surgery for high-risk prostate cancer has completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 evaluation of 18F-DCFBC PSMA-based PET imaging for detecting metastatic prostate cancer; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy [Phase 2]
Phase 2 clinical trial investigating arsenic trioxide for stage IV prostate cancer that progressed after hormone therapy has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating soy supplements in patients undergoing surgery for localized prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT) [NA]
The clinical trial evaluating contrast-enhanced transrectal ultrasonography to assess prostatic vascularity after radiotherapy for prostate …
-
CLINICAL_TRIALS trial_result · 2018-08-09Clinical Trial Update: The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer [Phase 3]
Phase 3 trial update evaluating safety and efficacy of 18F-Fluoromethylcholine PET/CT in prostate cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2018-08-09Clinical Trial Update: Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer [Phase 3]
Phase 3 trial evaluating PET tracers 68Ga-PSMA-11 vs 18F-Fluorocholine for prostate cancer recurrence.
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC [Phase 2]
Phase 2 trial investigating enzalutamide in combination with AZD5363 for metastatic castration-resistant prostate cancer (mCRPC).
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Spinal Morphine in Robotic Assisted Radical Prostatectomy [Phase 4]
Phase 4 clinical trial evaluating spinal morphine for analgesia during robotic-assisted radical prostatectomy completed.
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer [Phase 2]
Phase 2 trial update on magnetic resonance-guided high-dose brachytherapy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer [NA]
A prospective study using hybrid PET/MRI to evaluate men with suspected recurrence of prostate cancer after treatment.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC) [Phase 1, Phase 2]
Clinical trial update reports safety, pharmacokinetics and proof-of-concept results for ARN-509 (apalutamide) in castration-resistant prosta…